Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly Send to Friend Enquire before Buying Electronic (PDF)   Enterprisewide   Actelion Ltd - SWOT Analysis Datamonitor, May 2009, Pages: 25   Description     Table of Contents        Enquire before Buying    Send to a Friend   The Actelion Ltd - SWOT Analysis company profile is the essential source for top-level company data and information. Actelion Ltd - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Actelion is a biopharmaceutical company focused on the discovery, development and commercialization of synthetic, small-molecule drugs to address high unmet medical needs. The company has subsidiaries in more than 25 countries including the US, Canada, Brazil, Australia, Japan and Switzerland, which provide distribution, sales and marketing services. It has operations in Americas, Europe and Asia-Pacific. The company is headquartered in Allschwil, Switzerland and employed 1,900 people as of December 2008. The company recorded revenues of CHF1,473.5 million (approximately $1,365.1 million) during the financial year (FY) ended December 2008, an increase of 11.9% over FY2007. The increase was mainly due to strong sale of Tracleer. The operating profit of the company was CHF371.4 million (approximately $344 million) during FY2008, an increase of 160.4% over FY2007. The net profit was CHF321.5 million (approximately $297.8 million) in FY2008, an increase of 158% over FY2007. Scope of the Report - Provides all the crucial information on Actelion Ltd required for business and competitor intelligence needs - Contains a study of the major internal and external factors affecting Actelion Ltd in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Actelion Ltd -Data is supplemented with details on Actelion Ltd history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Actelion Ltd Reasons to Purchase - Support sales activities by understanding your customers’ businesses better - Qualify prospective partners and suppliers - Keep fully up to date on your competitors’ business structure, strategy and prospects - Obtain the most up to date company information available

		Top of page

All rights reserved. ? Copyright 2010 Research and Markets0    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster